Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Pulmotect Awarded Up To $6M From Department of Defense to Complete Two COVID-19 Trials

Posted on January 27, 2021January 27, 2021 by Brenton Scott

Posted in Press Releases

Post navigation

Coronavirus protection drug approved by FDA for testing in Houston
Pulmotect Appoints William J. Noss III as Chief Financial Officer
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2025
Pulmotect, Inc.